LONDON, UK, 12 May 2008, Curidium Medica plc, (LSE: CUR), the personalised medicine company focused on bringing the right drug to the right patient, announced today its Preliminary Results for the year ended 31 December 2007.
LONDON, UK, 12 May 2008, Curidium Medica plc, (LSE: CUR), the personalised medicine company focused on bringing the right drug to the right patient, announced today its Preliminary Results for the year ended 31 December 2007.
